Antibiotics to prevent pneumonia in ventilated patients
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether giving preventive antibiotics to adults on breathing machines lowers the risk of developing pneumonia during ventilation. It is a double-blind study, meaning neither you nor your doctor will know if you receive the antibiotic or a placebo.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be 18 years or older
- Currently on a breathing machine (ventilator)
- No signs of pneumonia or lung infection before starting ventilation
- Not currently taking antibiotics or taken them in the past week
- No known allergy to penicillin-like antibiotics
- Not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a fast respiratory test combined with a treatment plan can help doctors choose the right antibiotics sooner for patients in the intensive care unit who get pneumonia from a breathing machine. It aims to improve treatment and reduce unnecessary antibiotics.
This trial compares starting antibiotics right away versus waiting for more test results in people on a breathing machine who may have pneumonia. The goal is to find out which approach works better without causing harm.
This trial tests whether breathing in an antibiotic called polymyxin E can prevent pneumonia in people with brain injury who are on a breathing machine. It may help reduce lung infections in the ICU.
This study tests a new way to quickly diagnose pneumonia in children on breathing machines in the ICU. It uses information from the body and germs to find the right treatment faster.
This trial tests if inhaling a medication called colistin can prevent ventilator-associated pneumonia (a lung infection) in patients who are on a breathing machine. It aims to reduce the risk for those at high risk of getting an infection from drug-resistant bacteria.
This trial tests an “antibiotic stewardship” approach—choosing and adjusting antibiotics in a smarter way—for a first episode of pneumonia in patients on a breathing machine. It may help ensure the right antibiotics are used at the right time, while avoiding unnecessary or overly broad treatment.
Hear when a new Ventilator-Associated Pneumonia (VAP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.